Allergan Aesthetics received FDA approval for SKINVIVE by JUVÉDERM for improvement of neck appearance, expanding the product's labeled indications beyond its original cheek approval. SKINVIVE is a smooth, low-viscosity HA filler designed for superficial placement and gradual collagen stimulation—a positioning distinct from traditional volumizing fillers like JUVÉDERM Ultra or Voluma.
The neck approval is commercially significant: practitioners already inject this area off-label with various HA products, but labeled indication allows for direct marketing, formulary inclusion, and rebate-program eligibility. The décolletage and neck represent a high-volume, recurring-treatment zone—patients often return annually or bi-annually for maintenance, creating predictable revenue.